FY2025 · ended Dec 31, 2025 · Revenue $119.48M, +5.1% YoY · Filed Feb 13, 2026
Outset Medical, Inc. (OM) files with the SEC under industry code 3845, Electromedical & Electrotherapeutic Apparatus. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $119.5 million and a net loss of $81.7 million. Free cash flow was -$47.1 million. As of Jun 30, 2026 it held $147.2 million in cash and investments and $104.4 million in total debt.
Revenue (TTM)
$117.80M
-1.3% vs year-ago TTM
Net income (TTM)
$-74.29M
+24.1% vs year-ago TTM
Operating cash flow (TTM)
$-38.32M
+43.3% vs year-ago TTM
Free cash flow (TTM)
$-38.88M
+43.2% vs year-ago TTM
EPS (TTM)
$-4,078.42
+67.0% vs year-ago TTM
Dividend per share
None
Shares outstanding
18.31M
-66.0% vs prior year
Net cash
$42.74M
as of Jun 30, 2026
Operating margin
-56.1%
FY 2026
Company profile
- Industry
- Electromedical & Electrotherapeutic Apparatus (SIC 3845)
- Listed as
- OM (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Jose, CA
- SEC filer status
- Accelerated filer, Smaller reporting company
- SEC CIK
- 1484612
- Former names
- Home Dialysis Plus, Ltd. (until Feb 25, 2011)
Other Electromedical & Electrotherapeutic Apparatus companies
- Medtronic plc MDT
- LivaNova PLC LIVN
- Integer Holdings Corp ITGR
- Axogen, Inc. AXGN
- TransMedics Group, Inc. TMDX
- CONMED Corp CNMD
- Ceribell, Inc. CBLL
- InMode Ltd. INMD
All 31 Electromedical & Electrotherapeutic Apparatus companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $119.5M | $113.7M | $130.4M | $115.4M | $102.6M |
| Operating income | -$66.7M | -$113.4M | -$169.8M | -$161.0M | -$130.5M |
| Net income | -$81.7M | -$128.0M | -$172.8M | -$163.0M | -$131.9M |
| Diluted EPS | -$5.37 | -$36.96 | -$52.28 | -$3.38 | — |
| Operating cash flow | -$46.3M | -$116.3M | -$131.4M | -$145.7M | -$130.3M |
| Free cash flow | -$47.1M | -$117.2M | -$134.8M | -$154.1M | -$133.4M |
| Total assets | $264.5M | $275.8M | $313.8M | $400.1M | $463.5M |
| Total liabilities | $137.5M | $249.0M | $190.9M | $154.1M | $89.4M |
| Stockholders' equity | $127.0M | $26.8M | $122.9M | $246.0M | $374.1M |
| Cash and investments | $168.9M | $158.7M | $203.3M | $287.5M | $339.5M |
| Total debt | $101.2M | $201.9M | $136.2M | $103.2M | $37.8M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 4, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2026 | Nov 4, 2026 |
| 8-K |
Current report
Officer or director change
|
Aug 28, 2026 | Aug 27, 2026 |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| 8-K |
Current report
Material agreement, Results of operations
|
Jun 17, 2026 | Jun 14, 2026 |
All 743 Outset Medical, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.